Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer

Kathryn C. Arbour, Laura Mezquita, Niamh M. Long, +15

Journal of Clinical Oncology

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer

Laura Mezquita, Édouard Auclin, Roberto Ferrara, +19

JAMA Oncology

Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

Lizza Hendriks, Clémence Henon, Édouard Auclin, +20

Journal of Thoracic Oncology

Neuro-oncologyCheckpoint InhibitorsMedicineImmune Checkpoint InhibitorBrain Metastases Treated +7

CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17

Stéphanie Corgnac, Ines Malenica, Laura Mezquita, +19

Cell Reports Medicine

Osimertinib benefit inEGFR-mutant NSCLC patients withT790M-mutation detected by circulating tumour DNA

Jordi Remón, Caroline Caramella, Cécile Jovelet, +16

Annals of Oncology

OncologyTumour DnaSomatic VariantOncogenic AgentMedicine +5

Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma

Marie Auvray, Édouard Auclin, Philippe Barthélémy, +12

European Journal of Cancer

UrologyGenitourinary CancerMedicineNivolumab-ipilimumab FailurePharmacology +5

Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression

Mihaela Aldea, Lizza Hendriks, Laura Mezquita, +19

Journal of Thoracic Oncology

Neuro-oncologyTumor Dna AnalysisOncologyOncogenic AgentMedicine +5

Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort

Lina Sayah, Kathrin Heinrich, Volker Kunzmann, +16

European Journal of Cancer

Pancreatic CancerMedicineImmune Checkpoint InhibitorsImmunologyPathology +6

Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non–small cell lung cancer treated with immunotherapy

Ithar Gataa, Laura Mezquita, Caroline Rossoni, +17

European Journal of Cancer

Favourable OutcomeTumor ImmunologyCancer ImmunosurveillanceMedicineImmunology +9

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

Ali Chour, Julie Denis, Céline Mascaux, +27

Journal of Thoracic Oncology

MedicineLiver PhysiologyApoptosisPharmacologyBrief Report +9